Total raised
—
Last: Seed 2024-01
Stage
Seed
Founded
2023
Headcount
5
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
This company is a known business entity but lacks sufficient data to support a standard Finder profile.
Funding history · 1 round · — total
2024-01
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary business of Novolight DX?
- Novolight DX specializes in Hematological Analysis Devices.
- When was Novolight DX founded?
- Novolight DX was founded in June 2023.
- What is the current operational status of Novolight DX?
- Novolight DX is currently inactive, having ceased operations in August 2025.
- Where is Novolight DX headquartered?
- Novolight DX is headquartered in Tel Aviv-Yafo, Israel.
- Has Novolight DX raised any funding?
- Novolight DX secured Seed funding in January 2024, with Israel Innovation Authority as a lead investor. For full financing history, refer to startupim.
- What is the estimated employee count for Novolight DX?
- Novolight DX has an estimated employee count of 1-10, with 5 employees.
- Who are the founders of Novolight DX?
- The founders of Novolight DX are Ben Leshem and Ittai Madar.
- In which sector does Novolight DX primarily operate?
- Novolight DX primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B
Tags
stealthmodeblood-testhematology